Abstract:
Introduction
Marbofloxacin is a broad spectrum antibacterial agent which is very
effective against a broad range of bacterial pathogens. The pharmacokinetic
study of marbofloxacin is not conducted up till now in domestic ruminant
species. So, there is a need to conduct pharmacokinetic study of
marbofloxacin in order to select optimal dosage regimen in indigenous
species.
Objectives
The study was conducted to compare inter and intra species
variations of pharmacokinetic parameters and to select the dosage regimen
of marbofloxacin in domestic ruminant species.
Study Design
Experimental study
Setting
Department of Pharmacology, Al-Nafees Medical College/Isra
University, Islamabad Campus, Islamabad and Livestock Experimental
Farm, Institute of Nutrition, University of Agriculture, Faisalabad.
Duration
July 2012 to December 2015.
vii
Material & Methods
Thirty two adult, healthy, non-lactating females, animals were
selected. 8 from each species of buffaloes, cows, sheep and goats of local
breed. Marbofloxacin was injected as a single intravenous injection at a
dose of 2.5 mg/kg body weight to each animal. Blood and urine samples
were collected at specific time intervals. The concentration of marbofloxacin
in blood and urine were determined by HPLC method. Data were subjected
to computer software WinNonlin® to obtain pharmacokinetic parameters.
Inter and intra species differences were observed by ANOVA followed by
Duncan’s Multiple Range Test.
. Results
The low values of t1/2 suggested the rapid distribution of
marbofloxacin in all four species. The values for the elimination half life (t1/2)
were insignificant to each other in all tested species. The volume of
distribution at terminal phase (Vdarea) and at steady state (Vss) was
comparable (p>0.05) and higher (p<0.05) in sheep and goats followed in
descending order in cows and buffaloes indicating the well distribution and
deep tissue penetration of drug. However, the mean values for Vc were
remarkably higher in sheep (2.5±0.14 L/kg) followed by goats (2.21±0.11
L/kg) and parallel values in buffaloes (0.76±0.013 L/kg) and cows (0.88±0.02
L/kg). Total body clearance (ClB) was expressed as L/h/kg, and it showed the
similar pattern to Vdarea and Vss in local ruminants. The value of AUC was
viii
significantly (p<0.05) higher in buffaloes (8.37±0.50 μg.h/mL) followed by
cows (4.46±0.30 μg.h/mL), and parallel (p>0.05) values in sheep (2.08±0.05
μg.h/mL) and goats (2.16±0.04 μg.h/mL). In vitro the values of plasma
protein binding of marbofloxacin were 32.2%, 27.01%, 20.15% and 21.17%
in buffaloes, cows, sheep and goats respectively. The MIC50 and MIC90
values for marbofloxacin against Staphylococcus aureus species were
observed to be 0.5 and 1.0μg/ml respectively with MIC range of 0.125-2.0
μg/mL.
Endogenous creatinine was used as an index of glomerular filtration
rate (GFR) and recorded to be 0.87 ± 0.06 mL/min/kg in buffaloes, 0.98 ±
0.05 mL/min/kg in cows, 1.29 ± 0.079 mL/min/kg in sheep and 1.49 ± 0.103
mL/min/kg in goats. The renal clearance of marbofloxacin was measured as
1.96 ± 0.51 mL/min/kg in buffaloes, 2.08 ± 0.46 mL/min/kg in cows, 1.83 ± 0.54
mL/min/kg in sheep, 2.15 ± 0.53 mL/min/kg in goats. In the renal handling of
marbofloxacin, glomerular filtration and tubular secretion were involved in all
ruminant species.
Conclusion
The dosage regimen of marbofloxacin was higher in domestic
ruminants as compared to its foreign counterparts.
Keywords
Marbofloxacin, Domestic Animals, Pharmacokinetics, Renal Clearanc,
HPLC.